Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil
Launched by HERLEV HOSPITAL · Feb 10, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
**Clinical Trial Summary: Exploring Hypercalcemia from Paraffin Oil Injections**
This clinical trial is looking at a health issue called hypercalcemia, which is when there is too much calcium in the blood. This condition can sometimes happen after people receive injections of a substance called paraffin oil, used in certain medical treatments. The study aims to understand how this condition develops and progresses, and ultimately, to find new treatments that can help patients in the future. The researchers are currently recruiting participants who are between the ages of 65 and 74 and have previously received an intramuscular injection of paraffin or another type of oil.
If you choose to participate in this study, you'll be helping researchers learn more about the impacts of these injections on health, particularly in relation to kidney injury and other complications. While there are no specific exclusions based on health conditions, the main requirement is that you must have had a past injection of paraffin oil. Participating in this trial may involve various assessments to monitor your health and responses, and it offers a chance to contribute to important medical research that could benefit others facing similar health challenges in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • previous intramuscular injection of paraffin or other oil
- Exclusion Criteria:
- • none
About Herlev Hospital
Herlev Hospital, a leading healthcare institution located in Denmark, is dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a key player in the Danish healthcare system, Herlev Hospital combines cutting-edge facilities with a multidisciplinary approach to research, fostering collaborations among healthcare professionals and researchers. The hospital focuses on a wide range of medical fields, aiming to enhance treatment efficacy and patient care through rigorous scientific inquiry and ethical standards. With a commitment to excellence, Herlev Hospital plays a pivotal role in translating clinical research findings into practical applications that benefit patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, , Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials